These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 21397719

  • 1. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 2. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
    Kapteyn JC, Porre AM, de Rond EJ, Hessels WB, Tijms MA, Kessen H, Slotboom AM, Oerlemans MA, Smit D, van der Linden J, Schoen P, Thus JL.
    Vaccine; 2009 Feb 25; 27(9):1468-77. PubMed ID: 19110022
    [Abstract] [Full Text] [Related]

  • 3. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
    Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, Goudsmit J, Lagerwerf FM.
    Vaccine; 2006 Apr 12; 24(16):3137-44. PubMed ID: 16490287
    [Abstract] [Full Text] [Related]

  • 4. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, Li X, Wang J.
    Biologicals; 2010 Mar 12; 38(2):284-9. PubMed ID: 20074976
    [Abstract] [Full Text] [Related]

  • 5. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection.
    García-Cañas V, Lorbetskie B, Bertrand D, Cyr TD, Girard M.
    Anal Chem; 2007 Apr 15; 79(8):3164-72. PubMed ID: 17361989
    [Abstract] [Full Text] [Related]

  • 6. Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columns.
    Garcia-Cañas V, Lorbetskie B, Girard M.
    J Chromatogr A; 2006 Aug 11; 1123(2):225-32. PubMed ID: 16677659
    [Abstract] [Full Text] [Related]

  • 7. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP.
    Vaccine; 2010 Mar 11; 28(12):2442-9. PubMed ID: 20074687
    [Abstract] [Full Text] [Related]

  • 8. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 9. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y, Han L, Palladino G, Ferrari A, Xie Y, Carfi A, Dormitzer PR, Settembre EC.
    Vaccine; 2015 Oct 05; 33(41):5342-5349. PubMed ID: 26348403
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Haemagglutinin Content by RP-HPLC to Generate Pandemic Influenza Vaccine.
    Kang H, Roh HS, Song H, Lee K, Chung ST, Ban SJ, Mo IP, An BS, Ahn CY.
    Toxicol Res; 2016 Oct 05; 32(4):269-274. PubMed ID: 27818728
    [Abstract] [Full Text] [Related]

  • 11. A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography.
    Roh HS, Song HM, Yun BR, Kang HK, Choi KS, Park YJ, Kim DS, Kim SH, Mo IP, An BS, Ahn CY.
    Mol Med Rep; 2015 Apr 05; 11(4):2819-24. PubMed ID: 25482872
    [Abstract] [Full Text] [Related]

  • 12. HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
    Fulvini AA, Tuteja A, Le J, Pokorny BA, Silverman J, Bucher D.
    Vaccine; 2021 Jan 15; 39(3):545-553. PubMed ID: 33341306
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 14. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 23; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 15. Reversed phase monolithic analytical columns for the determination of HA1 subunit of influenza virus haemagglutinin.
    Urbas L, Košir B, Peterka M, Pihlar B, Strancar A, Barut M.
    J Chromatogr A; 2011 Apr 29; 1218(17):2432-7. PubMed ID: 21251658
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 17. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
    Khurana S, King LR, Manischewitz J, Coyle EM, Golding H.
    Vaccine; 2014 Apr 17; 32(19):2188-97. PubMed ID: 24613520
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis.
    Mayner RE, Blackburn RJ, Barry DW.
    Dev Biol Stand; 2014 Apr 17; 39():169-78. PubMed ID: 414948
    [Abstract] [Full Text] [Related]

  • 19. Assessment of viral replication in eggs and HA protein yield of pre-pandemic H5N1 candidate vaccine viruses.
    Jing X, Soto J, Gao Y, Phy K, Ye Z.
    Vaccine; 2013 Aug 28; 31(38):4091-7. PubMed ID: 23867014
    [Abstract] [Full Text] [Related]

  • 20. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay.
    van Kessel G, Geels MJ, de Weerd S, Buijs LJ, de Bruijni MA, Glansbeek HL, van den Bosch JF, Heldens JG, van den Heuvel ER.
    Vaccine; 2012 Jan 05; 30(2):201-9. PubMed ID: 22107849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.